Getting More Value out of XBRL Filing

Starting from 22 April 2015, all SingPass holders have been able to access the BizFinx portal to generate a Free Data Analysis (FDA) report which previously was available only to company directors and secretaries of companies that file XBRL financial statements with ACRA. The FDA report provides analysis on four key financial ratios which covers:

  • Trend analysis up to 5 years on the performance of a selected company; and
  • Benchmarking the selected company’s performance against industry medians and up to 3 peer companies

For more details on the FDA report, please visit

Source: Accounting and Corporate Regulatory Authority

Anti-money Laundering and Counter-financing of Terrorism Resources for Professional Accountants
Tax Guide for New Companies